Research Article
Target Groups for a Short Dexamethasone Course among Critically Ill COVID-19 Patients
Table 4
Multivariable stepwise logistic regression analysis of 28-day ICU mortality predictors.
| | Variable | All patients | IMV patients | IMV patients <65 years | | OR | 95% CI | value | OR | 95% CI | value | OR | 95% CI | value |
| | Dexamethasone | 0.41 | 0.16–1.00 | 0.049 | — | — | — | 0.17 | 0.03–0.84 | 0.030 | | Age | 1.12 | 1.07–1.16 | <0.001 | 1.11 | 1.06–1.17 | <0.001 | 1.24 | 1.05–1.47 | 0.013 | | Male sex | — | — | — | — | — | — | — | — | — | | Comorbidities | — | — | — | — | — | — | — | — | — | | Lactate | — | — | — | — | — | — | — | — | — | | Creatinine | 1.01 | 1.00–1.01 | 0.036 | 1.02 | 1.00–1.03 | 0.014 | 1.03 | 1.00–1.05 | 0.022 | | Lung injury on chest CT scan | — | — | — | — | — | — | — | — | — | | Anti-interleukin-6 receptor MABs | — | — | — | –— | — | — | — | — | — | | IMV | 24.60 | 7.35–82.80 | <0.001 | NA | NA | NA | NA | NA | NA |
|
|
CT, computed tomography; ICU, intensive care unit; IMV, invasive mechanical ventilation; MABs, monoclonal antibodies; NA, not applicable. Bold values denote statistical significance.
|
